Biosynthesis of interleukin-6, an autocrine growth factor for melanoma, is regulated by melanoma-derived histamine

This publication has 15 references indexed in Scilit:

• Histidine Decarboxylase Expression in Human Melanoma
  Journal of Investigative Dermatology, 2000
• Histamine and histamine-receptor antagonists modify gene expression and biosynthesis of interferon γ in peripheral human blood mononuclear cells and in CD19-depleted cell subsets
  Immunology Letters, 1999
• Inhibitory activity of loratadine and descarboxyethoxyloratadine on histamine-induced activation of endothelial cells
  Clinical and Experimental Allergy, 1997
• gp130 AND THE INTERLEUKIN-6 FAMILY OF CYTOKINES
  Annual Review of Immunology, 1997
• Prostaglandin E₂ Induces Interleukin‐6 Synthesis in Human Astrocytoma Cells
  Journal of Neurochemistry, 1997
• In vitro effect of histamine and histamine H1 and H2 receptor antagonists on cellular proliferation of human malignant melanoma cell lines
  Melanoma Research, 1996
• Adenosine A_2b Receptors Mediate an Increase in Interleukin (IL)‐6 mRNA and IL‐6 Protein Synthesis in Human Astroglioma Cells
  Journal of Neurochemistry, 1996
• Stimulation of the sphingomyelin pathway induces interleukin-6 gene expression in human astrocytoma cells
  Journal of Neuroimmunology, 1995
• Interleukin-6 undergoes transition from paracrine growth inhibitor to autocrine stimulator during human melanoma progression.
  The Journal of cell biology, 1993
• Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors.
  The Journal of cell biology, 1990